David L. Brinkley, Senior VP Commercial Development at THERAVANCE INC (THRX), sold 4,439 shares at $22.78 ($100K) on 2007-12-14, disclosed to the SEC on 2007-12-14.
Scheduled sale ($100k) by Senior VP Commercial Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.50 | 700 | $16K | 15.7% |
| 2 | $22.52 | 600 | $14K | 13.5% |
| 3 | $22.53 | 497 | $11K | 11.2% |
| 4 | $22.54 | 100 | $2K | 2.2% |
| 5 | $22.56 | 203 | $5K | 4.6% |
| 6 | $22.57 | 100 |
| $2K |
| 2.3% |
| 7 | $22.60 | 300 | $7K | 6.8% |
| 8 | $22.61 | 100 | $2K | 2.3% |
| 9 | $22.62 | 300 | $7K | 6.8% |
| 10 | $22.63 | 100 | $2K | 2.3% |
| 11 | $22.65 | 900 | $20K | 20.3% |
| 12 | $22.70 | 300 | $7K | 6.8% |
| 13 | $22.78 | 100 | $2K | 2.3% |
| 14 | $22.79 | 125 | $3K | 2.8% |
| 15 | $23.00 | 14 | $322 | 0.3% |
| Total | $22.59 avg | 4,439 | $100K | 100% |
| Filing → |
| THRX | SELL | 2013-05-07 | $561K | — | Filing → |
| THRX | SELL | 2013-05-02 | $577K | — | Filing → |
| THRX | SELL | 2012-08-28 | $96K | — | Filing → |